Article Information
History
- May 15, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Theresa Burkard1,#,
- Kim López-Güell1,#,
- Martí Català1,
- Edward Burn1,
- Antonella Delmestri1,
- Sara Khalid1,
- Annika M Joedicke1,
- Daniel Dedman2,
- Jessie O Oyinlola2,
- Alicia Abellan3,
- Laura Pérez-Crespo3,
- Núria Mercadé-Besora1,3,
- Talita Duarte-Salles3,4,
- Daniel Prieto-Alhambra1,4,*,
- Johnmary T Arinze4,
- Mees Mosseveld4,
- Raivo Kolde5,
- Jaime Meléndez-Cardiel6,
- Raúl López-Blasco6,
- Álvaro Martínez7,
- Bernardo Valdivieso7,8,
- Dominique Delseny9,
- Gregoire Mercier9,10,
- Chungsoo Kim11,
- Ji-woo Kim12,
- Kristin Kostka1,13,
- Juan Manuel Ramírez-Anguita14,
- Miguel A Mayer14,
- Nhung TH Trinh15,
- Hedvig ME Nordeng15,16,
- Roger Paredes17,18,19,
- Anneli Uusküla20,
- Akihiko Nishimura21,
- Cora Loste18,19,22,
- Lourdes Mateu18,19,22,23 and
- Junqing Xie1
- 1Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK
- 2CPRD, Medicines and Healthcare products Regulatory Agency, London, UK
- 3Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain
- 4Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, the Netherlands
- 5Institute of Computer Science, University of Tartu, Tartu, Estonia
- 6Biocomputing Unit, Aragon Health Sciences Institute (IACS), Zaragoza, Spain
- 7The Health Research Institute Hospital La Fe (Instituto de Investigación Sanitaria La Fe), Avenida Fernando Abril Martorell, 106 Torre A 7a planta, 46026, Valencia, Spain
- 8The University and Polytechnic La Fe Hospital of Valencia, Avenida Fernando Abril Martorell, 106 Torre H 1a planta, 46026, Valencia, Spain
- 9Public Health Department, University Hospital of Montpellier, 34295 Montpellier, France
- 10IDESP, Université de Montpellier, INSERM, 34000 Montpellier, France
- 11Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Republic of Korea
- 12Big Data Department, Health Insurance Review and Assessment Service, Wonju, Republic of Korea
- 13The OHDSI Center at the Roux Institute, Northeastern University, Portland, ME, USA
- 14Parc de Salut Mar, Hospital del Mar Medical Research Institute, Barcelona, Spain
- 15Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway
- 16Department of Child Health and Development, Norwegian Institute of Public Health, Oslo, Norway
- 17Center for Global Health and Diseases, Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH
- 18Department of Infectious Diseases & irsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol, Badalona, Catalonia, Spain
- 19Chair in Infectious Diseases and Immunity, Center for Health and Social Care Research (CEESS), Faculty of Medicine. University of Vic-Central University of Catalonia (UVic-UCC).
- 20Institute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia
- 21Department of Biostatistics, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA
- 22REICOP (Red de Investigación Covid Persistente), Madrid, Spain
- 23Universitat Autònoma de Barcelona, Catalonia, Spain
- ↵*Corresponding author:
Prof Daniel Prieto-Alhambra, Pharmaco- and Device Epidemiology Group, Health Data Sciences, Botnar Research Centre, NDORMS, University of Oxford, Oxford, UK; daniel.prietoalhambra{at}ndorms.ox.ac.uk
↵# these authors contributed equally
Posted May 15, 2024.
The risks of autoimmune- and inflammatory post-acute COVID-19 conditions: a network cohort study in six European countries, the US, and Korea
